ALPL

ALPL

ALPL 詳細

Molecule Name
Alkaline phosphatase, tissue-nonspecific isozyme
分子の別称
AP-TNAP, APTNAP, HOPS, HPPA, HPPC, HPPI, HPPO, TNALP, TNAP, TNS-ALP, TNSALP
Drug Development Progress
治験薬の数3
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
Alkaline Phosphatase, Biomineralization Associated,EC:3.1.3.1,Alkaline Phosphatase Liver/Bone/Kidney Isozyme,Liver/Bone/Kidney-Type Alkaline Phosphatase,ALPL,AP-TNAP,Alkaline Phosphatase, Liver/Bone/Kidney,Tissue Non-Specific Alkaline Phosphatase,TNSALP,Alkaline Phosphatase, Tissue-Nonspecific Isozyme,Tissue-Nonspecific ALP,EC 3.1.3.1,APTNAP,TNALP,TNAP,HOPS
バックグランド
This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects.

ALPL 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
ALXN-1850ALXN-1850Phase 3 ClinicalAlexion Pharmaceuticals Inc
Hypophosphatasia
詳細
DS-1211DS-1211Phase 2 ClinicalDaiichi Sankyo Co Ltd, Sanford Burnham Prebys Medical Discovery Institute
Ossification, Heterotopic; Pseudoxanthoma Elasticum
詳細
ALXN-1910ALXN-1910Phase 1 ClinicalAlexion Pharmaceuticals Inc
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Asfotase alfasTNALP-FcD10; ALXN-1215; sALP-FcD10; ENB-0040ApprovedAlexion Pharmaceuticals IncStrensiqJapanHypophosphatasiaAlexion Pharmaceuticals Inc2015-07-03
Hypophosphatasia
詳細